Alerts will be sent to your verified email
Verify Email
MANKIND
|
Mankind Pharma
|
Zydus Lifesciences
|
Dr. Reddy's Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.33 % | 18.47 % | 15.68 % |
|
5yr Avg Net Profit Margin
|
17.68 % | 19.02 % | 15.18 % |
|
Price to Book
|
7.25 | 4.16 | 3.18 |
|
P/E
|
54.93 | 21.8 | 18.81 |
|
5yr Avg Cash Conversion Cycle
|
-13.08 Days | -84.89 Days | 74.48 Days |
|
5yr Average Interest Coverage Ratio
|
46.07 | 30.19 | 35.66 |
|
5yr Avg ROCE
|
25.06 % | 19.65 % | 21.82 % |
|
5yr Avg Operating Profit Margin
|
24.62 % | 24.4 % | 23.61 % |
|
5 yr average Debt to Equity
|
0.16 | 0.17 | 0.12 |
|
5yr CAGR Net Profit
|
9.49 % | 16.23 % | 23.71 % |
|
5yr Average Return on Assets
|
14.46 % | 12.22 % | 11.24 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.68 % | 74.99 % | 26.64 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.82 % | 0.11 % | -0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.51 % | 0.94 % | -0.6 % |
|
Mankind Pharma
|
Zydus Lifesciences
|
Dr. Reddy's Lab
|
|---|